Precision BioSciences, Inc.
DTIL
$4.70
-$0.20-4.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.00K | 638.00K | 576.00K | 49.90M | 17.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.00K | 638.00K | 576.00K | 49.90M | 17.58M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 29.00K | 638.00K | 576.00K | 49.90M | 17.58M |
| SG&A Expenses | 9.33M | 7.96M | 9.30M | 9.08M | 9.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.14M | 25.48M | 21.85M | 25.75M | 21.77M |
| Operating Income | -22.11M | -24.85M | -21.28M | 24.15M | -4.19M |
| Income Before Tax | -20.57M | -17.75M | -16.43M | 32.75M | 8.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.57M | -17.75M | -16.43M | 32.75M | 8.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.57M | -17.75M | -16.43M | 32.75M | 8.59M |
| EBIT | -22.11M | -24.85M | -21.28M | 24.15M | -4.19M |
| EBITDA | -21.72M | -24.39M | -20.56M | 25.24M | -3.04M |
| EPS Basic | -2.21 | -2.22 | -2.25 | 4.70 | 1.70 |
| Normalized Basic EPS | -1.39 | -1.32 | -1.46 | 2.96 | 1.11 |
| EPS Diluted | -2.21 | -2.22 | -2.25 | 4.67 | 1.70 |
| Normalized Diluted EPS | -1.39 | -1.32 | -1.46 | 2.94 | 1.11 |
| Average Basic Shares Outstanding | 9.29M | 8.00M | 7.29M | 6.97M | 5.06M |
| Average Diluted Shares Outstanding | 9.29M | 8.00M | 7.29M | 7.01M | 5.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |